The restenosis rate after stent implantation is higher in small (Ͻ3.0 mm reference diameter) versus large coronary arteries (1) (2) (3) . Randomized, observational studies have found that stent-selected lesions located in small vessels lead to results equivalent to or better than those achieved with balloon angioplasty (4 -8) . Kastrati et al. (9) recently demonstrated that the use of a thinner strut device is associated with a significant reduction in angiographic and clinical restenosis after coronary artery stenting in vessels with a reference diameter Ͼ2.8 mm.
The purpose of the present study was to evaluate whether strut thickness may impact the restenosis rate after stent implantation in small coronary arteries.
METHODS
Patient group. From March 1996 to April 2001, 2,911 consecutive patients with 3,334 lesions underwent coronary stent implantation in small (Ͻ3.0 mm reference diameter) native coronary arteries in two institutions. All patients with self-expandable stents (n ϭ 57), coil stents (n ϭ 208), covered stents (n ϭ 4) radioactive stents (n ϭ 100), a combination of different stents (n ϭ 973) and atherectomy (both rotational and directional; n ϭ 81) were excluded from the analysis. Patients with successful stent placement and no major adverse cardiac events (MACE) during the first 30 days after the intervention were considered eligible for angiographic follow-up. After the exclusion of 65 patients in whom the procedure failed (success rate 96%) and 75 patients who developed at least one MACE during the first 30 days (30-day incidence of MACE 4.9%), all other patients were asked to undergo coronary angiography at six months or earlier if they had recurrence of symptoms. Angiographic follow-up was available in 821 (57%) of the 1,447 patients at an average of 8 Ϯ 2 months after the procedure. Therefore, the final study group included consisted of 821 consecutive patients with 941 lesions successfully treated with slotted-tube or multicellular stent implantation, or both, in small coronary arteries. All patients gave written, informed consent for both the intervention and follow-up angiography. Stent implantation procedure. Intracoronary stenting was performed using techniques previously described (10) . All patients received 325 mg aspirin before stent deployment. All patients received 70 IU/kg of an intra-arterial bolus of unfractionated heparin. Glycoprotein IIb/IIIa inhibitors were administered according to the operator's preference. Definitions. All stents with a strut thickness Ͻ0.10 mm were considered as thin, whereas all stents with a strut thickness Ն0.10 mm were considered as thick (11 Postprocedural management and follow-up. After successful stent implantation was achieved, no further heparin was administered, and the sheaths were removed in 4 to 6 h. Aspirin (325 mg/day) and ticlopidine (250 mg twice daily for 30 days) were prescribed to all patients. Follow-up was performed in all patients by means of an interview or telephone conversation with the patient or with the referring physician. Follow-up angiography was performed at six months, unless an early re-study was indicated by symptoms.
Angiographic measurements were performed, as previously described, with an automated computer-based system (QCA-CMS version 3.0, MEDIS, Leiden, The Netherlands) (12) . The lesions were characterized according to the modified American College of Cardiology/American Heart Association classification (13 of angiographic measurements in the three subgroups was performed by using proper, mixed linear model contrasts and by adjusting the p value using the Tukey approach for multiple comparisons. The SAS Proc Mixed (Cary, North Carolina) was used to obtain maximal likelihood solutions of the mixed linear models. The influence of clinical, angiographic and procedural variables on restenosis was evaluated by univariate and stepwise logistic regression analyses. All variables with a p value Ͻ0.10 in the univariate analysis were entered into the multivariate model of restenosis to test for independent effects. The analysis was made per lesion. A p value of Ͻ0.05 was considered statistically significant. Data were analyzed with SPSS version 10.0 (SPSS Inc., Chicago, Illinois) for Windows.
RESULTS
The thin group included 400 patients with 505 lesions. Thin stents included the Palmaz-Schatz (39.5%), ACS Multilink (9.2%), Biodyvisio (10.2%), BeStent (10%), Jostent Flex (4%), Diamond (7.6%), V-Flex (5.6%) and Carbostent (13.9%). The thick group included 421 patients with 436 lesions. Thick stents were the NIR (25.5%), ACS Duet (33.5%), BX Velocity (18%), AVEII (18%), Crossflex LC (2.8%) and Bard XT (2.2%). Clinical characteristics. Patients in the thin group were more often diabetics and had a lower rate of multivessel disease (Table 1) . Angiographic and procedural characteristics. The reference artery size was similar between the two groups. In contrast, there were significant differences in MLD, percent DS, lesion length, target vessel distribution, lesion type and lesion site (Table 2) . Indeed, the lesions were more often complex (e.g., B2/C), longer and located in the ostium in the thick group versus the thin group. Intravascular ultrasonography was performed more often in the thin group than in the thick group (63% vs. 33%; p Ͻ 
Strut Thickness and Restenosis 0.001), whereas direct stenting was similar (10%) for both groups (p ϭ 0.90). The balloon-to-artery ratio and inflation pressure were higher in the thin group than in the thick group (1.3 Ϯ 0.2 atm vs. 1.2 Ϯ 0.2 atm and 15 Ϯ 3 atm vs. 14 Ϯ 3 atm, respectively; p Ͻ 0.001 for both). Acute gain was higher in the thin group, whereas the final MLD was similar between the two groups ( (Fig. 2) . As represented in Figure 3 , the loss index was similar in vessels with a reference diameter Յ2.50 mm, although it was lower in the thin group, as the reference vessel diameter increased, and it was statistically lower only in vessels with a reference diameter between 2.76 and 2.99 mm.
DISCUSSION
The main result of the present study is that strut thickness appears to be an independent predictor of restenosis after stent implantation in vessels with a reference diameter Ͻ3.0 mm. The implantation of stents with a thin (Ͻ0.10 mm) strut may reduce the restenosis rate in small coronary arteries. In particular, implantation of thin-strutted stents implies an adjusted risk reduction of 56% for angiographic restenosis. The restenosis rate observed in the thin group was lower, even when there was a higher percentage of diabetic patients and a longer final stent length, both of which are well-known unfavorable factors of the long-term outcome, especially in small vessels (1, 2) . The lesions in the thick group were predisposed to restenosis by being more complex, longer and more commonly located in the ostium. The favorable effect of thin struts was clinically apparent only in vessels with a reference diameter between 2.76 and 2.99 mm. The loss index was significantly lower for stents implanted in vessels that were 2.76 to 2.99 mm (Fig. 3) , despite no difference in relative gain ( Table 4 ). The fact that no advantage was found in very small vessels supports the concept that the modest benefit obtained by stents with a thin strut cannot override the small residual lumen present in very small vessels. This may be due to the relatively high metal/vessel ratio present when a stent is implanted in a small vessel. Small artery size, as assessed by angiography, is an independent risk factor for the occurrence of restenosis and MACE at follow-up after stent implantation (1-3) . The proposed mechanisms of such an unfavorable outcome are: 1) a high degree of vessel stretch and injury; 2) a small postprocedural lumen; and 3) a high metal density. Vascular injury and foreign body reaction are important mechanisms by which stent implantation can provoke neointimal hyper- Briguori et al. August 7, 2002:403-9 Strut Thickness and Restenosis plasia (14 -16) . Understanding the factors involved in vascular injury imposed during stent deployment might allow optimization of the stent design (e.g., stent/strut geometry and stent material) to reduce restenosis. A number of stent configurations are now available. Differences have been reported in flexibility, tracking ability, expansion, radiovisibility, side-branch access and resistance to compression and recoil. Four different direct comparisons of first-generation Palmaz-Schatz slotted-tube stents and second-generation stents have been made ("stent vs. stent" equivalency trials). In three studies (17) (18) (19) , there were no significant differences in restenosis at follow-up, including MLD, percent DS, late loss and the binary restenosis rate. Randomized trials often include selected patients who are generally not representative of "real-life" stenting. Selected subsets may lead to equalization of outcomes and mask differences among the devices being tested (20) . Strut thickness and vessel damage. Kastrati et al. (9) recently demonstrated that the use of a device with a thinner strut is associated with a significant reduction in angiographic and clinical restenosis after coronary artery stenting in vessels Ͼ2.8 mm in reference diameter. The adjusted risk of restenosis associated with the thin-strutted stent was 0.42 (95% CI 0.26 to 0.68). One mechanism of stent-induced damage is strut-imposed vascular injury, which corresponds the extent of intimal thickening in experimental animals (14, (21) (22) (23) . The struts of the expanding stent impose focal, deep vascular trauma in comparison to the less controlled stretching and fracturing of the vessel wall caused by balloon inflation alone (23) . In addition to the deep injury associated with stent expansion, more superficial vascular injury occurs during stent expansion in areas removed from stent struts themselves. Furthermore, Rogers et al. (15) demonstrated that, using stents with a similar total surface area and strut thickness but a different geometric configuration, the stent design in which the struts created a more complex and closed area (corrugated-ring design) permitted 33% less injury in the spaces bounded by each strut, as compared with the stent design in which the inter-strut areas were more simple and open in shape (slotted-tube design). Study limitations. This is a nonrandomized, retrospective study. Furthermore, the rate angiographic follow-up was low. However, it was similar in the two groups (56% in the thin group vs. 57% thick group; p ϭ 0.80); therefore, any potential selection bias should be equally distributed in the two groups. Conclusions. This study supports the concept that strut thickness is an independent predictor of angiographic restenosis in coronary arteries with a reference diameter of 2.76 
